Celon Pharma S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was PLN 194.59 million compared to PLN 199.11 million a year ago. Net loss was PLN 39.28 million compared to PLN 11.61 million a year ago.

Basic loss per share from continuing operations was PLN 0.77 compared to PLN 0.25 a year ago. Diluted loss per share from continuing operations was PLN 0.77 compared to PLN 0.25 a year ago.